Dr. Shabir Ahmad Ganai is currently working as Assistant Professor Cum Junior Scientist, Division of Basic Sciences and Humanities, Faculty of Agriculture, SKUAST-Kashmir, Wadura, Sopore, 193201, Jammu & Kashmir, India. He has done his masters in Biochemistry from Bangalore University (2005-2007) and earned his Ph.D. from elite SASTRA University (2009-2014). Later, he did his post-doctorate from National Brain Research Centre, Haryana, India. He has also served as research fellow in SKUAST-Kashmir. His research interests are focused on understanding the modulations of the nuclear geometry and post-translational modifications during treatment with structurally distinct HDAC inhibitors. He has been actively involved in designing the target-selective inhibitors against Class II HDACs using various bioinformatics tools.
Dr. Shabir Ahmad Ganai has published more than 20 research articles and one editorial in high impact factor international Journals. He has also served as guest editor for a thematic issue (Epigenetics: A novel frontier for drug discovery) published by Current Medicinal Chemistry. In addition, he serves as a referee for many reputed international journals like Current Drug Targets, PLOS ONE and Medicinal Chemistry Research. He is an active member of many national and international societies including, The International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT).